Kwang Lee
Direttore Finanziario/CFO presso SquareX Pharmaceuticals Corp.
Profilo
Kwang Lee is currently a Partner at Ravix Group, Inc. and the Chief Financial Officer at SquareX Pharmaceuticals Corp.
Previously, he worked as a Senior Director at Bayhill Therapeutics, Inc. Mr. Lee obtained an undergraduate degree and an MBA from San Jose State University.
Posizioni attive di Kwang Lee
Società | Posizione | Inizio |
---|---|---|
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Direttore Finanziario/CFO | 01/10/2022 |
Ravix Group, Inc.
Ravix Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kingsway Financial Services, Inc., Ravix Group, Inc. provides accounting, financial and human resources consulting services. The company is based in San Jose, CA. The company was founded by Dan Saccani. Dan Saccani has been the CEO since incorporation. Ravix Group was acquired by Kingsway Financial Services, Inc. on October 04, 2021 for $15.50 million. | Corporate Officer/Principal | 01/01/2012 |
Precedenti posizioni note di Kwang Lee
Società | Posizione | Fine |
---|---|---|
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Direttore/Membro del Consiglio | - |
Formazione di Kwang Lee
San Jose State University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
Ravix Group, Inc.
Ravix Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kingsway Financial Services, Inc., Ravix Group, Inc. provides accounting, financial and human resources consulting services. The company is based in San Jose, CA. The company was founded by Dan Saccani. Dan Saccani has been the CEO since incorporation. Ravix Group was acquired by Kingsway Financial Services, Inc. on October 04, 2021 for $15.50 million. | Commercial Services |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Health Technology |
- Borsa valori
- Insiders
- Kwang Lee